Illumina, Inc. vs Williams-Sonoma, Inc. — how do they compare? Illumina, Inc. trades at $191.33 (market cap $29.12B), while Williams-Sonoma, Inc. trades at $246.23 (market cap $29.51B). The key difference: Illumina, Inc. and Williams-Sonoma, Inc. are close in size by market cap, and Williams-Sonoma, Inc. pays a 1.21% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | WSM | |
|---|---|---|
Market Cap | $29.12B | $29.51B |
Sector | Health | Consumer Cyclical |
52-Week High | $205.10 | $251.81 |
52-Week Low | $91.00 | $168.64 |
Enterprise Value | $30.48B | $30.35B |
Dividend Yield | — | 1.21% |
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $191.79, up 2.04% today, with a neutral technical signal and strong fundamental recovery. The stock shows bullish moving averages but faces resistance near $194. Recent earnings beats and a return to profitability in 2025, with $850M net income, highlight operational turnaround. Revenue remains stable around $4.3B, supported by robust gross margins of 66.38%.
Outlook is positive with analyst consensus Buy rating and $201.58 price target, though high P/E of 35.98 poses valuation risk. Key opportunities include sequencing demand and AI partnerships, while risks involve debt levels and competitive pressures. Institutional activity is mixed, with some funds increasing stakes amid earnings momentum.
Williams-Sonoma (WSM) trades at $250.82, down 0.39% on the day, with strong profitability metrics including a 13.81% net income margin and 54.01% ROE. The stock shows a bullish technical trend, supported by moving averages, but RSI levels indicate overbought conditions. Recent earnings beats and a solid dividend history highlight operational strength, though valuation ratios like P/E of 28.09 suggest premium pricing. News coverage remains active, focusing on earnings potential and competitive positioning in the home furnishings sector.
WSM presents a mixed outlook: robust fundamentals and consistent earnings beats support upside, but high valuation and technical overbought signals pose near-term risks. Investor sentiment is cautiously optimistic, with a Moderate Buy analyst consensus and a $231.10 price target slightly below current levels. Key risks include consumer discretionary volatility and competitive pressures, while institutional interest and dividend payments offer stability.
Trailing returns across standard periods
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →